Clinical Trial Update: A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection. [Phase 1, Phase 2]

View source ↗

Summary

A proof-of-concept study of VCH-759 for chronic hepatitis C infection in Phase 1 and Phase 2 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• VCH-759 (VCH-759)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C, Chronic | Phase 1, Phase 2 | Status: COMPLETED